ArticleEMBO reports2020
Exclusion or exemption from risk regulation?: A comparative analysis of proposals to amend the EU GMO legislation.
Article in EMBO reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- What farmers think about using crop biotechnology to boost photosynthesis in rice and potato.Scientific reports · 2026Article
- The Medicinal Phage-Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation.Viruses · 2024Article
- How French culture influences the framing of genetic modifications on the internet: Insights from Google-based corpus analysis.PloS one · 2024Article
- New genomic techniques, old divides: Stakeholder attitudes towards new biotechnology regulation in the EU and UK.PloS one · 2024Article
- Regulation of GMO field trials in the EU and new genomic techniques: will the planned reform facilitate experimenting with gene-edited plants?Biotechnologia · 2023Review
- New genomic techniques and their European Union reform. Potential policy changes and their implications.Frontiers in bioengineering and biotechnology · 2022Article
- Regulatory approaches for genome edited agricultural plants in select countries and jurisdictions around the world.Transgenic research · 2021Review
- Impacts of the regulatory environment for gene editing on delivering beneficial products.In vitro cellular & developmental biology. Plant : journal of the Tissue Culture Association · 2021Article
- Exclusion or exemption from risk regulation?: A comparative analysis of proposals to amend the EU GMO legislation.EMBO reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The EU Court of Justice's decision that gene-edited plants should be regulated as GMOs triggered various proposal to amend the EU Directive on the release of GMOs in the environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.